Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found a significant association between baldness patterns, particularly vertex and early-onset baldness, and an increased risk of prostate cancer.

In this study, women with metabolic and mixed-type alopecia showed different coping strategies; metabolic alopecia patients predominantly used adaptive strategies like problem-solving, while those with mixed alopecia often exhibited maladaptive strategies such as avoidance, with these behaviors being linked to higher levels of psychological maladjustment.

This study reviews the use of natural products, like herbal extracts and essential oils, in treating male pattern baldness, noting their potential benefits compared to conventional therapies that may carry side effects or ethical concerns.

This review concluded that low-dose oral minoxidil is an effective and well-tolerated treatment for male androgenetic alopecia, with significant hair density improvements and manageable side effects.

In this preliminary study, selenium-resistant bacteria and selenium-treated pea sprout extracts showed minimal inhibitory effects on the dandruff-associated fungus Malassezia furfur compared to controls, suggesting potential for further investigation.

This study found that trichoscopic parameters in male androgenetic alopecia deteriorated progressively with increasing disease severity and were significantly linked to genetic, metabolic, and psychosocial factors.

This study found that among male and female patients at a dermatology clinic, higher severity of androgenetic alopecia was statistically associated with lower sexual function scores, although the findings should be interpreted cautiously due to sample size and methodological limitations.

This review highlights a polyherbal hair formulation that combines various natural ingredients, reporting potential benefits in improving scalp circulation, strengthening hair, and promoting regrowth, which might offer a safer alternative for managing male pattern baldness compared to synthetic drugs.

This study determined that men taking finasteride 1 mg/day exhibited significantly reduced sperm production and morphology compared to controls, although there were no notable changes in hormonal, sexual, or psychological function.

This study found that a combined treatment using autologous scalp‐derived micrografts and allogeneic dental pulp stem cell‐derived conditioned medium was well-tolerated and improved hair characteristics in 69.5% of patients with male androgenetic alopecia, particularly increasing hair diameter and hair number per follicular unit.

This study found that the use of high pH chemical agents for hair straightening can cause significant damage to hair, including protein degradation and weakened fiber strength, and may lead to permanent scalp conditions like contact dermatitis and cicatricial alopecia.

EfficientNet improves accuracy in diagnosing hair loss stages.

Minoxidil and finasteride are recommended for male pattern baldness.

Minoxidil and finasteride are recommended for male pattern baldness.

This review reports that 5-alpha reductase inhibitors, used to treat androgenic alopecia, may adversely affect sperm count, sexual function, and hormones in a subset of patients.

In this case report, researchers observed that apple cider vinegar used as a topical antimicrobial agent effectively improved skin condition and reduced lesions associated with scabiosis and malasseziosis in a 3-year-old domestic cat, with noticeable results in 7 days.

This study found that men taking 1 mg/day of finasteride had significantly reduced sperm production and morphology but similar hormonal, sexual, and psychological profiles compared to controls, suggesting finasteride affects semen quality without altering other physiological functions.

This study reviews the complexities of burn-related skin complications, highlighting postburn pruritus, dyspigmentation, and the risk of malignant ulcers, while offering a framework for evidence-based management through various treatment approaches.

The study developed herbal shampoo formulations using isolated phytoconstituents, such as eugenol, rutin, menthol, and camphor, which demonstrated similar antifungal efficacy to ketoconazole but with improved safety and detergency, offering a promising alternative for managing seborrheic dermatitis.

In this study, topical finasteride 0.25% showed sustained effectiveness over 52 weeks, especially in the frontotemporal areas of men with androgenetic alopecia, while maintaining an excellent safety profile.

This study developed consensus guidelines for the use of low-dose oral and topical minoxidil in male and female pattern hair loss, recommending specific doses, monitoring procedures, and timing of application around hair transplant surgeries.

This study developed expert consensus guidelines on using low-dose oral and topical minoxidil for pattern hair loss around hair transplant surgery, recommending specific doses, monitoring practices, and timing of use for both male and female patients.

This study developed consensus guidelines for using low-dose oral and topical minoxidil in patients undergoing hair transplant surgery for pattern hair loss, recommending dosing adjustments, monitoring protocols, and timing for post-surgery application.

This case report describes a 4-month-old domestic dog suffering from emaciation alongside Malasseziosis and Ehrlichiosis, showing significant clinical improvement after treatment, including dietary changes, medicated bathing, antiparasitic, antibiotic therapy, and supportive care.

In this case report, a 3-month-old puppy with Malassezia dermatitis showed substantial improvement and complete recovery from pruritus, skin lesions, and hair loss after four weeks of treatment with Sebazole® shampoo, apple cider vinegar, virgin coconut oil, and diphenhydramine.

This study suggests that neither autologous platelet-rich plasma nor 5% topical minoxidil reliably outperforms the other as a monotherapy for male androgenetic alopecia, with combination therapy often showing superior outcomes.

This study reviewed treatments and findings related to male androgenetic alopecia, noting that topical minoxidil and oral finasteride are effective for slowing hair loss, while newer interventions like PRP and microneedling show promise.

This review discusses the epidemiology, pathophysiology, diagnosis, and management of male androgenetic alopecia, noting that combination treatments, including FDA-approved and emerging therapies, may improve outcomes without added side effects.

In this study, researchers identified 47 proteins associated with male pattern baldness severity and prioritized five candidate genes, including druggable CD38, suggesting new non-hormonal targets for therapeutic development.

This review suggests a shift toward genetically informed treatments for male pattern hair loss by integrating genetic insights and pharmacogenetic markers into therapeutic decision-making.